FDA/FTC/CDCObesity

Dangers of Internet “natural” diet pills

 There’s a long list of contaminated diet pills, many with sibutramine (Meridia), that the FDA has ordered off the market in the US. It’s likely that many consumers see these products as a neat way to circumvent getting a prescription.

Now, doctors from the University of Freiburg in Germany have documented the problems encountered by some of these “smart” people.

First, the details.

  • 17 documented cases of poisoning from 2005 to 2008 were reviewed.
  • In 4 cases, toxicological analyses of leftover capsules and urine samples were performed.

And, the results.

  • Symptoms experienced by the patients
    • Malaise (13 of 17 patients)
    • Rapid heart rate (7)
    • Headache (4)
    • Agitation (5)
    • High blood pressure (3)
    • Nausea (4)
    • Dyspnea (3)
    • Vomiting (3)
    • Insomnia (2)
    • Chest pressure (1)
    • Fever (1)
  • A 17-year old female patient had a minor increase in creatine kinase (muscle breakdown? heart toxicity?).
    • She had taken 1 to 3 capsules daily over 5 weeks.
  • A 14-year old girl took the diet capsules with atomoxetine (Strattera) and methylphenidate (Ritalin) for ADHD.
    • She was treated for agitation and confusion.
  • A man became psychoic after taking the diet pills.
    • He was also taking chlorprothixene (an antipsychotic), olanzapine (Zyprexa to treat schizophrenia), and cipramil (to treat depression).
  • Analysis of the contents of the capsules revealed levels of silbutramine that were twice that contained in a legal prescription drug in Germany.

The bottom line?
Information for these patients came from 2 poison control centers. So, it probably underestimates the number of patients treated at local emergency departments during this time.

In certain patients with underlying psychological conditions, taking Internet diet pills increased the risk of agitation, confusion, and even psychosis.

For the rest of us, these “natural” products can lead to a broad range of bothersome side effects.

The authors advise that patients should share information about their use of these drugs with their doctor, and healthcare professionals should ask about them when taking a medication history.

4/11/09 21:33 JR

Hi, I’m JR

John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.